(For treatment side effects and complications only)
Ipilimumab with Nivolumab Combination treatment in Malignant Pleural Mesothelioma V1.1
Ipilimumab with Nivolumab Combination treatment in Malignant Pleural Mesothelioma Compassionate Access Scheme V1.0
Nivolumab Pleural or Peritoneal Mesothelioma (Unlicensed Use) Protocol V1.0
Ramucirumab and Gemcitabine Maligant Pleural Mesothelioma V1.0